App & Fitbit Monitoring for Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of a digital app and Fitbit in managing type 2 diabetes among African American adults. Participants will receive diabetes education and learn appetite control through web-based lessons as part of the DSME + ASE intervention (Centering Appetite). The goal is to improve blood sugar levels and reduce binge eating. African American individuals with type 2 diabetes, high blood sugar levels (HbA1c > 7.5), and a smartphone are ideal candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative diabetes management strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to consult with the trial coordinators for specific guidance.
What prior data suggests that this app and Fitbit monitoring method is safe for African American adults with type 2 diabetes?
Research shows that learning to manage diabetes independently, known as Diabetes Self-Management Education (DSME), effectively handles type 2 diabetes. Studies have found that DSME helps individuals better understand diabetes and care for themselves, often leading to improved blood sugar control and weight management.
The Appetite Self-Regulation (ASE) program, which includes mindful eating, has shown promise. It helps individuals with diabetes manage their weight and blood sugar levels effectively.
Digital tools, such as apps and devices like Fitbits, are safe and widely used to track health information. They enable individuals to monitor their activity and stay engaged in their health journey.
Overall, the DSME + ASE program is well-received and considered safe. Research has not reported any major negative side effects, making it a promising option for managing type 2 diabetes.12345Why are researchers excited about this trial?
Researchers are excited about the DSMES + ASE intervention for type 2 diabetes because it offers a new approach to managing the condition by focusing on appetite self-regulation. Unlike traditional treatments that primarily focus on medication and diet, this method helps participants relearn to recognize their body's hunger and fullness signals, which could lead to more effective glucose management. Additionally, the use of a digital app for delivering interactive lessons and telehealth sessions makes it more accessible and engaging, providing support and education in a convenient and modern way.
What evidence suggests that this app and Fitbit monitoring is effective for type 2 diabetes?
Research shows that learning to manage diabetes independently can significantly benefit people with type 2 diabetes. Studies have found that such education can lower HbA1c levels, a key measure of blood sugar control, by up to 1.27%. This reduction is crucial for managing diabetes. In this trial, participants in the DSMES + ASE intervention arm will practice mindful eating, which has shown promise for controlling weight and blood sugar. By using a digital app and Fitbit, participants can enhance these benefits by tracking physical activity and monitoring progress. Overall, these strategies work together to improve blood sugar levels and reduce binge eating in people with type 2 diabetes.12467
Who Is on the Research Team?
Rachel Goode, PhD, MPH, LCSW
Principal Investigator
University of North Carolina at Chapel Hil
Are You a Good Fit for This Trial?
This trial is for African American adults with type 2 diabetes who experience binge eating. They must be over 18, have an HbA1c level above 7.5, and own a working smartphone. It's not for those with major diabetes complications, substance use treatment, involvement in other weight programs, history of weight loss surgery or current pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-month digital diabetes self-management education program plus an appetite self-regulation intervention
Follow-up
Participants are monitored for changes in weight, binge eating episodes, blood pressure, and HbA1C
What Are the Treatments Tested in This Trial?
Interventions
- DSME + ASE intervention (Centering Appetite)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
American Diabetes Association
Collaborator